Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological treatment of pediatric Gaucher disease
Punita Gupta, Gregory M. Pastores
Expert Review of Clinical Pharmacology (2018) Vol. 11, Iss. 12, pp. 1183-1194
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

GBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Giulietta Riboldi, Alessio Di Fonzo
Cells (2019) Vol. 8, Iss. 4, pp. 364-364
Open Access | Times Cited: 244
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?
Neal J. Weinreb, Özlem Göker-Alpan, Priya S. Kishnani, et al.
Molecular Genetics and Metabolism (2022) Vol. 136, Iss. 1, pp. 4-21
Open Access | Times Cited: 44
Gaucher disease – more than just a rare lipid storage disease
Jaehyeok Roh, Subbaya Subramanian, Neal J. Weinreb, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 4, pp. 499-518
Closed Access | Times Cited: 32
Exploring the efficacy and safety of Ambroxol in Gaucher disease: an overview of clinical studies
Feda E. Mohamed, Fatma Al‐Jasmi
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy
Noa Hurvitz, Tama Dinur, Shoshana Revel‐Vilk, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3325-3325
Open Access | Times Cited: 6
Effect of LRRK2 Inhibition on the Activity of Glucocerebrosidase in Patient-Specific Cells from Patients with Gaucher Disease
Tatiana Usenko, Katerina Basharova, Anastasia Bezrukova, et al.
Biochemistry (Moscow) (2025) Vol. 90, Iss. 1, pp. 99-106
Closed Access
Newborn Screening for Gaucher Disease: The New Jersey Experience
Caitlin Menello, Shaney Pressley, Madeline Steffensen, et al.
International Journal of Neonatal Screening (2025) Vol. 11, Iss. 2, pp. 34-34
Open Access
Current and emerging pharmacotherapy for Gaucher disease in pediatric populations
Richard Sam, Emory Ryan, Emily Daykin, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 11, pp. 1489-1503
Open Access | Times Cited: 25
Neuronopathic Gaucher disease: Rare in the West, common in the East
Özlem Göker-Alpan, Margarita M. Ivanova
Journal of Inherited Metabolic Disease (2024) Vol. 47, Iss. 5, pp. 917-934
Open Access | Times Cited: 3
Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysis
Meimei Wang, Fengqin Li, Jing Zhang, et al.
Journal of Pediatric Hematology/Oncology (2022) Vol. 45, Iss. 4, pp. 181-188
Open Access | Times Cited: 14
The role of glucosylsphingosine as an early indicator of disease progression in early symptomatic type 1 Gaucher disease
Ashlee R. Stiles, Erin Huggins, Luca Fierro, et al.
Molecular Genetics and Metabolism Reports (2021) Vol. 27, pp. 100729-100729
Open Access | Times Cited: 14
Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene
Esperanza Lepe Balsalobre, José Diego Santotoribio, Ramiro Núñez, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 58, Iss. 12, pp. 2017-2024
Open Access | Times Cited: 11
Screening for Gaucher Disease Using Dried Blood Spot Tests: A Japanese Multicenter, Cross-sectional Survey
Toshihiro Miyamoto, Masaki Iino, Yasuji Komorizono, et al.
Internal Medicine (2021) Vol. 60, Iss. 5, pp. 699-707
Open Access | Times Cited: 9
Metabolomic Study Using Time-of-Flight Mass Spectrometry Reveals Novel Urinary Biomarkers for Gaucher Disease Type 1
Iskren Menkovic, Michel Boutin, Abdulfatah Alayoubi, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 5, pp. 1321-1329
Closed Access | Times Cited: 5
Newborn Screening in Gaucher Disease: A Bright and Complicated Future
Emory Ryan, Tiffany Jong, Ellen Sidransky
OBM Genetics (2022) Vol. 06, Iss. 03, pp. 1-21
Open Access | Times Cited: 3
Gaucher disease in children: what has changed in the 21st century
М. Б. Белогурова, Yu. V. Dinikina, D.А. Kudlаy, et al.
Russian Journal of Pediatric Hematology and Oncology (2020) Vol. 6, Iss. 4, pp. 19-24
Open Access | Times Cited: 3
Case report: Multidisciplinary collaboration in diagnosis and treatment of child gaucher disease
Jianfang Zhu, Yuxiao Sun, Weiyan Zheng, et al.
Frontiers in Pediatrics (2023) Vol. 11
Open Access | Times Cited: 1
Gaucher's disease in children: Case report from Afghanistan with literature review
Turyalai Hakimi, Omran Omar Amarkhil, Muhammad Arif Zamani, et al.
Global Pediatrics (2023) Vol. 5, pp. 100072-100072
Open Access | Times Cited: 1
Velaglucerase alfa for treatment in children with Gaucher disease type 1: the Russian experience
G. B. Movsisyan, Kirill V. Savostyanov, А. А. Пушков, et al.
Pediatric Hematology/Oncology and Immunopathology (2023) Vol. 22, Iss. 3, pp. 94-102
Open Access | Times Cited: 1
Clinical Outcomes of Patients with Chronic Neuropathic Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective Study
Sinziana Stanescu, Patricia Correcher Medina, Francisco Castillo, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2861-2861
Open Access | Times Cited: 1
Diffusion tensor imaging of vertebral bone marrow in children with Gaucher's disease type I and III: Pre- and post-therapy
Ahmed Abdel Khalek Abdel Razek, Saher Taman, Walaa Gamal, et al.
Clinical Imaging (2021) Vol. 79, pp. 207-212
Closed Access | Times Cited: 2
Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature
Gabriela Ręka, Martyna Stefaniak, Monika Lejman
Cells (2023) Vol. 12, Iss. 3, pp. 449-449
Open Access
Rare Diffuse Lung Diseases of Genetic Origin
Paolo Spagnolo, Nicol Bernardinello
Springer eBooks (2023), pp. 487-502
Closed Access
Challenges of Clinical Research in Orphan Diseases
Paolo Spagnolo, Nicol Bernardinello
Springer eBooks (2023), pp. 11-21
Closed Access
Nutritional Approach in Selected Inherited Metabolic Cardiac Disorders—A Concise Summary of Available Scientific Evidence
Alina-Costina Luca, Ioana-Alexandra Pădureț, Viorel Ţarcă, et al.
Nutrients (2023) Vol. 15, Iss. 22, pp. 4795-4795
Open Access
Page 1 - Next Page

Scroll to top